Kezar Life Sciences, Inc. (KZR) Misses Q4 EPS by 6c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q4 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks